SUVEN

Suven Life Sciences Share Price

₹129.50 +2.2 (1.73%)

05 Nov, 2024 17:31

SIP TrendupStart SIP in SUVEN

Start SIP

Performance

  • Low
  • ₹126
  • High
  • ₹133
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹169
  • Open Price₹127
  • Previous Close₹127
  • Volume236,270

Investment Returns

  • Over 1 Month -8.9%
  • Over 3 Month -9.03%
  • Over 6 Month + 13.85%
  • Over 1 Year + 66.13%
SIP Lightning

Smart Investing Starts Here Start SIP with Suven Life Sciences for Steady Growth!

Suven Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -19.3
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 2,824
  • P/B Ratio
  • 10.5
  • Average True Range
  • 7.76
  • EPS
  • -0.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -5.65
  • RSI
  • 46.67
  • MFI
  • 38.65

Suven Life Sciences Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations2.571.012.392.453.06
Total Income From Operations2.571.012.392.453.06
P/L Before Interest, Excpt. Items & Tax-11.06-7.64-4.10-4.73-4.66
P/L Before Exceptional Items & Tax-11.07-7.67-4.13-4.77-4.70
P/L After Tax from Ordinary Activities-11.07-7.67-3.12-4.772.76
Net Profit/Loss For the Period-11.07-7.67-3.12-4.772.76
IndicatorMar 24Mar 23
Revenue From Operations [Gross]11.6913.54
Revenue From Operations [Net]11.6913.54
Total Operating Revenues11.6913.54
Total Revenue32.8221.99
Total Expenses49.2948.12
Profit/Loss Before Tax-9.01-20.13
Profit/Loss For The Period-8.01-20.13
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-20.56-10.09
Net Cash Used In Investing Activity-0.68-361.66
Net Cash Used in Finance Activity-1.05395.54
Net Inc/Dec In Cash And Equivalent-22.3023.79
Cash And Equivalent End Of Year4.4026.70
IndicatorMar 24Mar 23
Total Share Capital21.8121.81
Total Non-Current Liabilities1.352.46
Total Current Liabilities4.764.54
Total Capital And Liabilities851.48860.44
Total Non-Current Assets605.34619.18
Total Current Assets246.14241.26
Total Assets851.48860.44
Indicator20242023
EBIT Margin (%)-139.47-190.83
Return On Capital Employed (%)-1.92-3.01
Return On Equity (%)-0.94-2.35
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)38.7739.14
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations2.571.012.392.453.06
Total Income From Operations2.571.012.392.453.06
P/L Before Interest, Excpt. Items & Tax-49.63-28.02-27.51-41.73-20.09
P/L Before Exceptional Items & Tax-49.64-28.04-27.54-41.76-20.14
P/L After Tax from Ordinary Activities-49.64-28.04-26.54-41.76-12.68
Net Profit/Loss For the Period-49.64-28.04-26.54-41.76-12.68
IndicatorMar 24Mar 23
Revenue From Operations [Gross]11.6913.54
Revenue From Operations [Net]11.6913.54
Total Operating Revenues11.6913.54
Total Revenue32.8221.99
Total Expenses146.36146.26
Profit/Loss Before Tax-106.08-118.27
Profit/Loss For The Period-105.08-118.27
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-115.47-103.15
Net Cash Used In Investing Activity94.44-260.65
Net Cash Used in Finance Activity-1.05395.54
Net Inc/Dec In Cash And Equivalent-22.0931.75
Cash And Equivalent End Of Year14.9337.02
IndicatorMar 24Mar 23
Total Share Capital21.8121.81
Total Non-Current Liabilities1.352.46
Total Current Liabilities13.5211.13
Total Capital And Liabilities284.90388.91
Total Non-Current Assets28.23137.32
Total Current Assets256.67251.59
Total Assets284.90388.91
Indicator20242023
EBIT Margin (%)-969.62-915.70
Return On Capital Employed (%)-41.77-32.81
Return On Equity (%)-38.91-31.51
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)12.3817.21

Suven Life Sciences Technicals

EMA & SMA

Current Price
₹129.50
+ 2.2 (1.73%)
pointer
  • stock-down_img
  • Bullish Moving Average 10
  • stock-up_img
  • Bearish Moving Average 6
  • 20 Day
  • ₹128.48
  • 50 Day
  • ₹133.88
  • 100 Day
  • ₹130.73
  • 200 Day
  • ₹119.60

Resistance and Support

127.44 Pivot Speed
  • R3 134.85
  • R2 132.43
  • R1 129.86
  • S1 124.87
  • S2 122.45
  • S3 119.88

Is Suven Life Sciences Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Suven Life Sciences Ltd. is a leading pharmaceutical company in India, specializing in the development of novel drug candidates and contract research services. The company focuses on CNS (central nervous system) disorders, providing innovative solutions for the global healthcare market. Suven Life Sciences has an operating revenue of Rs. 8.41 Cr. on a trailing 12-month basis. An annual revenue growth of 49% is outstanding, Pre-tax margin of -907% needs improvement, ROE of -38% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 7 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Suven Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-29 Quarterly Results
2024-08-05 Quarterly Results
2024-05-06 Audited Results
2024-01-30 Quarterly Results
2023-11-04 Quarterly Results

Suven Life Sciences F&O

Suven Life Sciences Shareholding Pattern

70.27%
1.05%
0.33%
0%
22.15%
6.2%
  • NSE Symbol
  • SUVEN
  • BSE Symbol
  • 530239
  • Chairman & Managing Director
  • Mr. Venkateswarlu Jasti
  • ISIN
  • INE495B01038

Suven Life Sciences FAQs

Suven Life Sciences share price is ₹129 As on 05 November, 2024 | 17:17

The Market Cap of Suven Life Sciences is ₹2824.1 Cr As on 05 November, 2024 | 17:17

The P/E ratio of Suven Life Sciences is -19.3 As on 05 November, 2024 | 17:17

The PB ratio of Suven Life Sciences is 10.5 As on 05 November, 2024 | 17:17

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form